Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
This introduction explains the 5-year rule for Roth IRAs and how it affects qualified withdrawals and tax treatment.
21,792 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
ClearPoint Neuro's earnings are under the microscope for investors watching the medical-device niche. This analysis b...
Global luxury housing markets are cooling from last year’s surge as demand moderates and inventories improve, signali...
Gold tumbles after the Federal Reserve narrows its rate-cut outlook, sliding from the $5,000 zone to around $4,500. T...
Palantir stock sits at a valuation well above the market average. This piece breaks down what that 2,500% gap means, ...
Memes have evolved from jokes into a serious branding engine. In 2026, chuck norris never dies: anchors licensing dea...
The Fed has stopped cutting rates, but that doesn’t mean investors should abandon Realty Income. This article explain...
Ciena shares surged on Monday thanks to upbeat analyst revisions and higher price targets. This article breaks down w...
BMO Capital Markets cuts Lithium Americas' price target to $4.50, citing 15% capex inflation at Thacker Pass and ongo...
As AI chatbots expand across industries, investors must weigh price, data controls and performance. This report break...
The AI hype cycle has investors chasing the next breakout. This article identifies a stock I would avoid and a choice...
BTIG raises its price target on FTAI Aviation after the company boosted 2026 EBITDA guidance, arguing that a recoveri...